P300: Long-term surgical outcomes following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis in a tertiary IBD centre in Brazil
ECCO '19 Copenhagen
2019
P301: A serological biomarker of type VIII collagen that contains the anti-angiogenic signalling molecule, vastatin, is associated with the extension of disease in ulcerative colitis
ECCO '19 Copenhagen
2019
P303: Hyperbilirubinemia can be induced with azathioprin treatment in patients with inflammatory bowel disease: a hospital-based cohort study
ECCO '19 Copenhagen
2019
P305: Platelet parameters evaluation as a non-invasive marker of inflammation in Crohn’s disease
ECCO '19 Copenhagen
2019
P306: Double balloon enteroscopy in paediatric Crohn’s disease and 10 years follow-up
ECCO '19 Copenhagen
2019
P307: The use of the patient safety form in patients with inflammatory bowel disease, can improve the low screening and starting HBV prophylaxis rates in real life
ECCO '19 Copenhagen
2019
P308: Utility of bowel ultrasound in diagnosing disease activity in Crohn’s disease: Indian experience
ECCO '19 Copenhagen
2019
P309: Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE study
ECCO '19 Copenhagen
2019
P310: Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
ECCO '19 Copenhagen
2019
P311: Pharmacokinetics and exposure–response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
ECCO '19 Copenhagen
2019
P312: Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate–severe ulcerative colitis: UNIFI
ECCO '19 Copenhagen
2019
P313: Impact of upadacitinib on the general clinical condition of patients with Crohn’s disease (CD): data from the randomised CELEST study
ECCO '19 Copenhagen
2019
P315: Systemic and tissue modulation of IL-23 pathway biomarkers in a Phase 2 study of risankizumab in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P316: Transanal minimal invasive proctectomy (TaMIP) for perineal Crohn’s disease; a multi-centre prospective cohort study
ECCO '19 Copenhagen
2019
P317: Characterisation of patients with delayed response to ustekinumab for Crohn’s disease
ECCO '19 Copenhagen
2019